Company / SG&A per Share
Praxis Precision Medicines, Inc. SG&A per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$3.04
FY2025
5-year range
$1.11 / $19.51
FY2021-FY2025
Trend
-52.5%
vs FY2024
Sector context
#63 of 210
Health Care
What the data says
At $3.04, Praxis Precision Medicines, Inc.'s sg&a per share ranks #148 of 210 in the Health Care sector. SG&A per Share has declined for 3 consecutive years, from $19.51 in FY2022 to $3.04 in FY2025.
Based on SEC 10-K filings.
3.04 in FY2025 with a 5-year CAGR of +9.9%.
Improved from $12.77 to $3.04 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- -46.2%
- 5-Year CAGR
- +9.9%
- 10-Year CAGR
- -
Sector benchmark
#148 of 210 in Health CareTop 70% of 210This company $3.04 Sector average $40.75
▼
-92.5% below sector average
Key checks
Key Insights
- Praxis Precision Medicines, Inc.'s sg&a per share has declined for 3 consecutive years.
- In FY2025, sg&a per share decreased 52.5% year-over-year.
- Ranks #63 out of 210 companies in the Health Care sector.
- Peak sg&a per share was recorded in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 4.48 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.04 | -52.5% |
| FY2024 | $6.40 | -49.9% |
| FY2023 | $12.77 | -34.5% |
| FY2022 | $19.51 | +1659.2% |
| FY2021 | $1.11 | -41.6% |
| FY2020 | $1.90 | -53.4% |
| FY2019 | $4.07 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026